RU2015155975A - SPRAY FOR ORAL USE CONTAINING ALPHOSERATE CHOLIN. - Google Patents

SPRAY FOR ORAL USE CONTAINING ALPHOSERATE CHOLIN. Download PDF

Info

Publication number
RU2015155975A
RU2015155975A RU2015155975A RU2015155975A RU2015155975A RU 2015155975 A RU2015155975 A RU 2015155975A RU 2015155975 A RU2015155975 A RU 2015155975A RU 2015155975 A RU2015155975 A RU 2015155975A RU 2015155975 A RU2015155975 A RU 2015155975A
Authority
RU
Russia
Prior art keywords
spray
alphoserate
cholin
oral use
use containing
Prior art date
Application number
RU2015155975A
Other languages
Russian (ru)
Other versions
RU2632718C2 (en
Inventor
Андрей Михайлович Гомжин
Владимир Григорьевич Тимко
Дмитрий Сергеевич Олейников
Роман Прокопьевич Савяк
Original Assignee
Общество с ограниченной ответственностью "Фармамед"
Общество с ограниченной ответственностью Научно-производственная фирма "Мiкрохiм"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Фармамед", Общество с ограниченной ответственностью Научно-производственная фирма "Мiкрохiм" filed Critical Общество с ограниченной ответственностью "Фармамед"
Priority to RU2015155975A priority Critical patent/RU2632718C2/en
Publication of RU2015155975A publication Critical patent/RU2015155975A/en
Application granted granted Critical
Publication of RU2632718C2 publication Critical patent/RU2632718C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Claims (3)

1. Композиция в форме спрея для орального применения, содержащая холина альфосцерат в количестве 30-70% мас., по меньшей мере, один растворитель, выбранный из этанола и воды, и вспомогательные вещества.1. A composition in the form of an oral spray containing choline alfoscerate in an amount of 30-70% by weight, at least one solvent selected from ethanol and water, and excipients. 2. Лекарственное средство, содержащее композицию по п. 1, в форме спрея для орального применения.2. A medicament containing a composition according to claim 1, in the form of an oral spray. 3. Биологически активная добавка, содержащая композицию по п. 1, в форме спрея для орального применения.3. A dietary supplement containing a composition according to claim 1, in the form of an oral spray.
RU2015155975A 2015-12-25 2015-12-25 Spray for oral application, containing choline alfoscerate RU2632718C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2015155975A RU2632718C2 (en) 2015-12-25 2015-12-25 Spray for oral application, containing choline alfoscerate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015155975A RU2632718C2 (en) 2015-12-25 2015-12-25 Spray for oral application, containing choline alfoscerate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2017135069A Division RU2684118C2 (en) 2017-09-27 2017-09-27 Spray for oral application containing choline alphocerate

Publications (2)

Publication Number Publication Date
RU2015155975A true RU2015155975A (en) 2017-06-30
RU2632718C2 RU2632718C2 (en) 2017-10-09

Family

ID=59309573

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015155975A RU2632718C2 (en) 2015-12-25 2015-12-25 Spray for oral application, containing choline alfoscerate

Country Status (1)

Country Link
RU (1) RU2632718C2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008134143A (en) * 2008-08-21 2010-02-27 Тимофей Георгиевич Кожока (RU) PHARMACEUTICAL COMPOSITION OF CITYCOLINE, CHOLIN ALPHOSCERATE AND L-CARNITINE (OR ACETYL-L-CARNITINE) FOR THE TREATMENT AND PREVENTION OF DISEASES OF THE CENTRAL NERVOUS SYSTEM AND METHOD
RU2380095C1 (en) * 2008-09-24 2010-01-27 Мераб Ревазович Кокеладзе Pharmaceutical composition of choline alphocerate expressing nootropic activity and cholinomimetic action, method for making thereof
RU2391095C1 (en) * 2009-02-05 2010-06-10 Закрытое акционерное общество "Березовский фармацевтический завод" Pharmaceutical composition including choline alfoscerate and hopantenic acid (or its salt) for treatment of cerebral circulatory insufficience and erectal dysfunction
RU2406506C1 (en) * 2009-08-17 2010-12-20 Мераб Ревазович Кокеладзе Pharmaceutical composition choline alphoscerate in form of solution for injections (cholitiline®) exhibiting nootropic activity and cholinomimetic action, method for treatment/prevention of cns diseases and effects of craniocereberal injures
IT1402907B1 (en) * 2010-11-30 2013-09-27 Ricerfarma Srl TOPIC COMPOSITIONS TO MAINTAIN OR RESTORE THE INTEGRITY OF THE MUCOSE.
RU2011151678A (en) * 2011-12-19 2013-09-27 Общество с ограниченной ответственностью "ФармИнтеллект" PHARMACEUTICAL COMPOSITION IN THE FORM OF INJECTION SOLUTION Possessing Nootropic, Neuroprotective and Anti-Alcoholic Activity and Method for its Preparation

Also Published As

Publication number Publication date
RU2632718C2 (en) 2017-10-09

Similar Documents

Publication Publication Date Title
HRP20220075T1 (en) A liquid formulation comprising nicotine for aerosol administration
HRP20210529T1 (en) Mk2 inhibitors and uses thereof
CL2016002148A1 (en) 2,4-disubstituted phenylene-1,5-diamine derivatives and applications thereof, and pharmaceutically acceptable pharmaceutical compositions and compositions prepared therefrom.
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
CO2018004776A2 (en) Therapeutic compositions for the treatment of human immunodeficiency virus
AR093705A1 (en) DEPSIPEPTIDE AND ITS USES
EA201492091A1 (en) PHARMACEUTICAL COMPOSITIONS FOR LOCAL APPLICATION CONTAINING TERBINAPHID AND UREA
EA201791009A1 (en) COMPOSITIONS CONTAINING CYCLOSPORIN
JP2017061576A5 (en)
RU2019110980A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A 15-HEPC AND METHODS FOR TREATING ASTHMA AND LUNG DISEASES WITH THEIR APPLICATION
WO2015125152A3 (en) Pharmaceutical compositions of asenapine
MX2017013099A (en) Methods for the treatment of inflammatory disorders.
EA201700356A1 (en) NEW CYCLOPROPANBENZOFURANILPYRIDOPYRAZINDIONS
MX2018014129A (en) Pharmaceutical composition comprising eteplirsen.
WO2015079067A3 (en) Various compounds as autophagy stimulants
WO2015002755A3 (en) Compounds for the treatment of malaria
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
WO2015001541A3 (en) Pharmaceutical film composition
CY1123394T1 (en) PHARMACEUTICAL COMPOSITION
MX2015010486A (en) Chewable composition for oral administration and process for preparing thereof.
EA201890477A1 (en) INCAPSULATED COMPOSITION OF FINGOLIMODA
WO2016020408A3 (en) Compounds for preventing ototoxicity
RU2015155975A (en) SPRAY FOR ORAL USE CONTAINING ALPHOSERATE CHOLIN.